Christian Adrian Macias Arguello

Dr. Christian Adrian Macias Arguello

Research Fellow, Surgical Excellence Academy, Dallas, Texas, USA
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2024 in Emerging Science Journal
Verified
Journal Article
Open access
PDF file
JCJorge Cornejo
Jorge Cornejo
MVM. Vargas
M. Vargas
MCM. Carvajal
M. Carvajal
PPPaul Perales
Paul Perales
GRG. Rodríguez
G. Rodríguez
EEEnrique F. Elli
Enrique F. Elli
Despite the location (Earth or Space), surgical simulation is a vital part of improving technical skills and ensuring patients' safety in the real procedure. The purpose of this study is to describe the Space System for Minimally Invasive Surgery (SY-MIS©) project, which started in 2016 under the supervision of the Center for Space Systems (C-SET). The process connects the best features of the following machines: Biomedik Surgeon, Space Biosurgeon, SP-LAP 1, and SP-LAP 2, which were defined using the VDI 2221 guidelines. This research uses methods based on 3 standards: i) Biomedical design: ISO 9001-13485 / FDA 21 CFR 820.30 / ASTM F1744-96(2016); ii) Aerospace human factors: HF-STD-001; iii) Mechatronics design: VDI 2206. The results depict the conceptual biomedical design of a novel training system named Surgical Engineering and Mechatronic System (SETY©), which integrates the use of 2 laparoscopic tools and 2 anthropomorphic mini-robotic arms (6 DOF). It has been validated by the Evaluation of Technical Criteria, getting a total score of 90% related to clinical assessment, machine adaptability, and robustness. The novelty of the research lies in the introduction of a new procedure that covers the simultaneous use of laparoscopic and robotic systems, named Hybrid Cyber-Physical Surgery (HYS©). In conclusion, the development of SY-MIS© promotes the use of advanced technologies to improve surgical procedures and human-machine medical cooperation for the next frontier of habitability on other planets. Doi: 10.28991/ESJ-2024-08-02-01 Full Text: PDF

13 July 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
AGAman Goyal
Aman Goyal
Christian Adrian Macias ArguelloChristian Adrian Macias Arguello
Christian Adrian Macias Arguello
MCMaria Paula Corzo
Maria Paula Corzo
VVVanessa Pamela Salolin Vargas
Vanessa Pamela Salolin Vargas
MMMathew Mendoza
Mathew Mendoza
Luigi MaranoLuigi Marano
Luigi Marano
Introduction: Gastrointestinal (GI) cancers are associated with high morbidity and mortality. Surgical resection, the primary treatment, often induces immunosuppression and increases the risk of postoperative complications. Perioperative immunonutrition (IMN), comprising formulations enriched with omega-3 fatty acids, arginine, nucleotides, and antioxidants, has emerged as a potential strategy to improve surgical outcomes by reducing complications, enhancing immune function, and promoting recovery. Methods: A systematic search of PubMed, Scopus, and the Cochrane Library was conducted on 28 October 2024 in accordance with PRISMA guidelines. Systematic reviews and meta-analyses evaluating perioperative IMN versus standard care in adult patients undergoing GI cancer surgery were included in the search. The outcomes assessed included infectious and non-infectious complications, wound healing, hospital stay, and nutritional status. The study quality was evaluated using AMSTAR 2, and the meta-analysis was conducted using random-effects models to calculate the pooled effect sizes (risk ratios [RRs], odds ratios [ORs], mean differences [MDs]) with 95% confidence intervals (CIs). Results: Sixteen systematic reviews and meta-analyses, including a total of 41,072 patients, were included. IMN significantly reduced infectious complications (RR: 0.62, 95% CI: 0.55–0.70; I2 = 63.0%), including urinary tract infections (RR: 0.74, 95% CI: 0.61–0.89; I2 = 0.0%) and wound infections (OR: 0.64, 95% CI: 0.55–0.73; I2 = 34.4%). Anastomotic leak rates were notably lower (RR: 0.68, 95% CI: 0.62–0.75; I2 = 8.2%). While no significant reduction in pneumonia risk was observed, non-infectious complications decreased significantly (RR: 0.83, 95% CI: 0.75–0.92; I2 = 30.6%). IMN also reduced the length of hospital stay by an average of 1.92 days (MD: −1.92, 95% CI: −2.36 to −1.48; I2 = 73.5%). Conclusions: IMN provides significant benefits in GI cancer surgery, reducing complications and improving recovery. However, variability in protocols and populations highlight the need for standardization and further high-quality trials to optimize its application and to validate its efficacy in enhancing surgical care.


17 February 2025 in Cancers
Verified
Journal Article
Open access
PDF file
AGAman Goyal
Aman Goyal
Christian Adrian Macias ArguelloChristian Adrian Macias Arguello
Christian Adrian Macias Arguello
MCMaria Paula Corzo
Maria Paula Corzo
Daniel TomeyDaniel Tomey
Daniel Tomey
SSSachin Shetty
Sachin Shetty
RORodolfo J Oviedo
Rodolfo J Oviedo
Introduction: Obesity is a chronic disease associated with increased risk for several cancers, including colorectal cancer (CRC), a leading cause of cancer-related mortality. The majority of CRC cases are associated with modifiable risk factors. Metabolic and bariatric surgery (MBS) is a proven, durable, and successful intervention for obesity. This study aimed to evaluate the impact of MBS on CRC risk through measures of association, such as relative risk (RR) and odds ratio (OR). Methods: A systematic search of PubMed, Scopus, Web of Science, ScienceDirect, and Embase was conducted to identify systematic reviews (SR) and meta-analyses examining the relationship between obesity treated with MBS and CRC incidence. The PICO framework guided inclusion criteria, and three independent reviewers screened articles using Rayyan software. Quality assessment was performed using AMSTAR2. Results: Of 1336 screened articles, 10 SR met inclusion criteria, encompassing 53,452,658 patients. Meta-analyses consistently showed a significant reduction in CRC risk following MBS in patients with severe obesity. Risk reductions were reported by Liu et al. (RR: 0.46, 95% CI: 0.32–0.67, p < 0.01), Chierici et al. (RR: 0.46, 95% CI: 0.28–0.75, p = 0.018), Wilson et al. (RR: 0.69, 95% CI: 0.53–0.88, p = 0.003), and Pararas et al. (RR: 0.56, 95% CI: 0.40–0.80, p < 0.001). Sensitivity analyses supported these findings. For colon cancer, Liu and Chierici both reported an RR of 0.75 (95% CI: 0.46–1.21, p = 0.2444) with significant heterogeneity (I2 = 89%). A trend towards reduced rectal cancer risk (RR: 0.74, 95% CI: 0.40–1.39, p = 0.3523) was noted but limited by fewer studies. Sex-specific analyses revealed protective effects in both sexes, with a more pronounced impact in females (RR: 0.54, 95% CI: 0.37–0.79, p = 0.0014). Conclusions: This umbrella review synthesizes current evidence on the impact of MBS on CRC risk, highlighting a consistent protective association. The findings also indicate a potential risk reduction for both colon and rectal cancer, with a more pronounced effect observed among females compared to males. Given the profound implications of MBS on cancer incidence, morbidity, and mortality, further high-quality, long-term studies are essential to deepen our understanding and optimize its role in cancer prevention and patient care.


12 September 2025 in Artificial Intelligence Surgery
Verified
Journal Article
Open access
PDF file
AGAman Goyal
Aman Goyal
MMMathew Mendoza
Mathew Mendoza
AMAlfonzo E. Munoz
Alfonzo E. Munoz
Christian Adrian Macias ArguelloChristian Adrian Macias Arguello
Christian Adrian Macias Arguello
AAAdel Abou-mrad
Adel Abou-mrad
RORodolfo J Oviedo
Rodolfo J Oviedo
Introduction: Artificial intelligence (AI) integration into surgical practice has advanced intraoperative precision, complication prediction, and procedural efficiency. While AI has demonstrated advancements in colorectal, cardiac, and other laparoscopic procedures, its application in inguinal hernia repair (IHR), one of the most commonly performed surgeries, remains underexplored. AI models demonstrate potential in real-time recognition of surgical phases, anatomical structures, and instruments, particularly in transabdominal preperitoneal (TAPP), total extraperitoneal (TEP), and robotic inguinal hernia repair (RIHR). This systematic review evaluates the accuracy, applicability, and clinical impact of AI-based systems in real-time surgical phase recognition during IHR. Methods: Following PRISMA 2020 guidelines and PROSPERO registration (CRD42024621178), a systematic search of PubMed, Scopus, Web of Science, Embase, Cochrane Library, and ScienceDirect was conducted on November 12, 2024. Studies utilizing AI models for real-time video-based surgical phase recognition in minimally invasive IHR (TAPP, TEP, and RIHR) were included. The screening process, data extraction task, and quality assessment using NOS (Newcastle-Ottawa Scale) were performed by three independent reviewers. Primary outcomes were AI performance metrics (accuracy, F1-score, precision, recall, and latency), and secondary outcomes included clinical phase recognition performance. Results: Out of 903 records, six studies (2022-2024) were included, involving laparoscopic (n = 4) and robotic-assisted (n = 2) IHR from the United States (n = 2), France (n = 2), and Greece (n = 1). A total of 774 videos (25-619 per study) underwent pre-processing (frame extraction or down-sampling). Annotation tools included CVAT, SuperAnnotate, and manual labeling. AI models (VTN, DETR, ResNet-50, YOLOv8) demonstrated accuracy between 74% and > 87%, with YOLOv8 achieving the highest F1-score (82%). Risk of bias was moderate to high, with Fleiss’ kappa for inter-rater agreement at 0.82 (selection) and 0.49 (comparability). Conclusion: AI and ML models demonstrate significant potential in achieving real-time surgical phase recognition during minimally invasive IHR. Despite promising accuracies, challenges such as heterogeneity in model performance, reliance on annotated datasets, and the need for real-time validation persist. Standardized benchmarks, multicenter studies, and hardware advancements will be essential to fully integrate AI into surgical workflows, improving surgical training, technical performance, and patient outcomes.